Implementing personalized medicine in diabetic kidney disease: Stakeholders' perspectives-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Implementing personalized medicine in diabetic kidney disease: Stakeholders' perspectives

Published:2018-10 Issue: Volume:20 Page:24-29
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

de Vries Jeroen K.¹,Levin Adeera²,Loud Fiona³,Adler Amanda⁴,Mayer Gert⁵,Pena Michelle J.⁶^ORCID

Affiliation:

1. Department of Internal Medicine; Antonius Ziekenhuis; Sneek the Netherlands

2. Division of Nephrology; University of British Columbia; Vancouver BC Canada

3. Kidney Care UK; Alton UK

4. Institute of Metabolic Sciences, Cambridge University; Cambridge UK

5. Department of Internal Medicine IV (Nephrology and Hypertension); Medical University of Innsbruck; Innsbruck Austria

6. Department of Pharmacy and Pharmacology; University Medical Center Groningen, University of Groningen; Groningen the Netherlands

Funder

Innovative Medicines Initiative

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.13412/fullpdf

Reference27 articles.

1. Mortality and cardiovascular disease in type 1 and type 2 diabetes;Rawshani;N Engl J Med,2017

2. Diabetic kidney disease: act now or pay later;Atkins;Nephrol Dial Transplant,2010

3. The health care costs of diabetic nephropathy in the United States and the United Kingdom;Gordois;J Diabetes Complicat,2004

4. The albuminuria-lowering response to dapagliflozin is variable and reproducible among individual patients;Petrykiv;Diabetes Obes Metab,2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection;International Journal of Molecular Sciences;2024-04-03

2. P32: a sex- and gender-sensitive model for evidence-based precision medicine: from knowledge generation to implementation in the field of kidney transplantation;Kidney International;2023-04

3. Renal Protective Mechanisms of Shenyuan Particle in Db/Db Mice: A Study Based on Network Pharmacology;Evidence-Based Complementary and Alternative Medicine;2022-06-14

4. Long-term effectiveness of a disease management program to prevent diabetic nephropathy: a propensity score matching analysis using administrative data in Japan;BMC Endocrine Disorders;2022-05-20

5. Perspectives on a Way Forward to Implementation of Precision Medicine in Patients With Diabetic Kidney Disease; Results of a Stakeholder Consensus-Building Meeting;Frontiers in Pharmacology;2021-05-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3